Name of License: Notice of Intent to Grant an Exclusive License
Summary: Notice is hereby given that the Department of Veterans Affairs (VA), Office of Research and Development, Technology Transfer Program, intends to grant to ePurines, Inc, 650 Komas Drive, Suite 104A, Salt Lake City, UT 84108, USA, an exclusive license to U.S. Patent No. 10,107,795 and U.S. Patent No. 10,024,846 associated with VA Invention Disclosure number 13-239 titled, “Composition and Methods for the Prevention and Treatment of Diet Induced Obesity”.
Tech Name:
Composition and Methods for the Prevention and Treatment of Diet Induced Obesity
Dates: Comments must be received on or before February 3, 2021.
Address: Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (202) 255-0613 (this is not a toll-free number), [email protected].
For Further Information Contact: Send comments to Ms. Patricia A. Cullum, Technology Transfer Specialist, Office of Research and Development (14RDTT), Department of Veterans Affairs, 810 Vermont Avenue, NW., Washington, DC 20420, (202) 255-0613 (this is not a toll-free number), [email protected].
Supplementary Information: The Federal Government’s patent rights in this invention are assigned to the US Government as represented by the Department of Veterans Affairs. It is in the public interest to license this invention as ePurines, Inc. has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within 15 days from the date of this published Notice, the Department of Veterans Affairs Office of Research and Development, Technology Transfer Program receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.